mortality/aging
• female mice treated with normal male levels of testosterone die after 9 days of treatment
|
• very few male mice survive to weaning
|
• male mice exhibit reduced viability at birth
• however, treatment with flutamide enhances male perinatal survival
|
muscle
• male mice exhibit atrophic and hypertrophic fibers, internal myonuclei, fiber splitting, altered myofibrillar organization and an overall increase in oxidative metabolism
• however, no inflammation is present in muscles and female mice treated with normal male levels of testosterone fail to exhibit muscle loss
|
• in male mice
|
• male mice exhibit decreased muscle fiber number by half in the extensor digitorum longus compared to in wild-type mice
|
• in male mice
|
• in male mice
|
behavior/neurological
• male mice and female mice treated with normal male levels of testosterone exhibit decreased motor function that precedes loss of body weight in the case of the females
• however, castration of males improves motor function
|
• in male mice
|
nervous system
• male mice exhibit fewer L5 motor axons than in wild-type mice without neuron loss
|
growth/size/body
• in male mice and female mice treated with normal male levels of testosterone
|
skeleton
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
Kennedy's disease | DOID:0060161 |
OMIM:313200 |
J:127205 |